Accordingly, the expression groups were established based on the median value obtained with the IHC assessment (median of 0 for c-MET and 33 for RhoA and CLDN18), as previously described in the methods sections (based on H-score for c-MET according to the percentage of stained tumor cells for RhoA and CLDN18). This evidence concerns the gene CLDN18 and neoplasm.